a month ago
VKTX
AnalystsJay OlsonJay Olson's Stock Forecasts
AnalystsJay Olson
Analyst Ranking
Top 3%
#115 out of 4560 analysts
Average Return
+18.62%
Win Rate
46%78 out of 168
Risk vs Reward
Poor
Good
Jay Olson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +578.03% | $2.64 | $17.90 | 2022-05-12 - 2023-05-12 | Buy |
89bio IncETNB | +450.31% | $3.22 | $17.72 | 2022-06-29 - 2023-06-29 | Buy |
Viking Therapeutics IncVKTX | +439.77% | $15.44 | $83.34 | 2023-03-27 - 2024-03-27 | Buy |
Madrigal Pharmaceuticals IncMDGL | +365.01% | $64.44 | $299.65 | 2022-05-09 - 2023-05-09 | Buy |
Prothena Corp Public Ltd CoPRTA | +357.12% | $12.08 | $55.22 | 2020-07-08 - 2021-07-08 | Buy |
Jay Olson Analyst Color
Get additional color on Jay Olson's coverage of popular stocks
a month ago
VKTX
2 months ago
VKTX
a year ago
VKTX
Jay Olson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 18 | Buy | $270.00 | +39.77% | Maintains | 5 days ago |
Sage Therapeutics IncSAGE | 6 | Hold | $17.00 | +31.27% | Maintains | 6 days ago |
Revolution Medicines IncRVMD | 6 | Buy | $45.00 | +24.10% | Maintains | 12 days ago |
Skye Bioscience IncSKYE | 1 | Buy | $25.00 | +78.19% | Initiates Coverage On | 12 days ago |
Q32 Bio IncQTTB | 1 | Buy | $50.00 | +96.08% | Initiates Coverage On | 13 days ago |
Ionis Pharmaceuticals IncIONS | 3 | Buy | $75.00 | +79.25% | Maintains | 15 days ago |
Sutro Biopharma IncSTRO | 4 | Buy | $10.00 | +168.82% | Maintains | 21 days ago |
Viking Therapeutics IncVKTX | 7 | Buy | $138.00 | +112.54% | Maintains | a month ago |
Cognition Therapeutics IncCGTX | 4 | Buy | $9.00 | +350.00% | Maintains | a month ago |
Madrigal Pharmaceuticals IncMDGL | 7 | Buy | $375.00 | +71.72% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 9 | Buy | $200.00 | +42.77% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 10 | Hold | $19.00 | +13.50% | Maintains | a month ago |
Marinus Pharmaceuticals IncMRNS | 5 | Hold | $9.00 | +525.00% | Maintains | 2 months ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $80.00 | +261.83% | Maintains | 2 months ago |
Immuneering CorpIMRX | 1 | Buy | $25.00 | +1,433.74% | Reiterates | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 8 | Buy | $80.00 | +289.11% | Maintains | 2 months ago |
Amgen IncAMGN | 16 | Buy | $350.00 | +27.95% | Reiterates | 3 months ago |
Biovie IncBIVI | 4 | Buy | $5.00 | +916.26% | Maintains | 5 months ago |
Enanta Pharmaceuticals IncENTA | 7 | Hold | $21.00 | +59.70% | Maintains | 5 months ago |
Intellia Therapeutics IncNTLA | 7 | Buy | $70.00 | +225.13% | Maintains | 5 months ago |
Immunogen IncIMGN | 1 | Hold | $16.00 | -48.77% | Initiates Coverage On | 7 months ago |
Exelixis IncEXEL | 3 | Buy | $29.00 | +24.52% | Maintains | 8 months ago |
Crispr Therapeutics AgCRSP | 5 | Buy | $102.00 | +80.82% | Reiterates | 8 months ago |
Mirati Therapeutics IncMRTX | 7 | Buy | $62.00 | +5.62% | Maintains | 8 months ago |
Voyager Therapeutics IncVYGR | 4 | Buy | $16.00 | +109.15% | Reiterates | 9 months ago |
Editas Medicine IncEDIT | 5 | Hold | $12.00 | +119.78% | Reiterates | 9 months ago |
Incyte CorpINCY | 7 | Buy | $92.00 | +78.12% | Reiterates | 9 months ago |
Galecto IncGLTO | 2 | Buy | $12.00 | +1,611.84% | Reiterates | 9 months ago |
Denali Therapeutics IncDNLI | 3 | Buy | $68.00 | +322.10% | Maintains | a year ago |
Cymabay Therapeutics IncCBAY | 3 | Buy | $16.00 | -50.74% | Maintains | a year ago |
89bio IncETNB | 4 | Buy | $30.00 | +236.32% | Reiterates | a year ago |
Karuna Therapeutics IncKRTX | 4 | Buy | $280.00 | -15.11% | Reiterates | a year ago |
Bicycle Therapeutics PLCBCYC | 2 | Buy | $55.00 | +142.50% | Reiterates | a year ago |
Seagen IncSGEN | 8 | Buy | $229.00 | N/A | Maintains | a year ago |
Nektar TherapeuticsNKTR | 2 | Hold | $3.00 | N/A | Maintains | a year ago |
Cincor Pharma IncCINC | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Ayala Pharmaceuticals IncAYLA | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Relmada Therapeutics IncRLMD | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Sierra Oncology IncSRRA | 2 | Hold | $55.00 | N/A | Downgrades | 2 years ago |
Focus Financial Partners IncFOCS | 1 | Buy | $71.00 | N/A | Maintains | 3 years ago |
Korro Bio IncKRRO | 2 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $46.00 | N/A | Downgrades | 4 years ago |
Tempest Therapeutics IncTPST | 1 | Hold | $2.00 | N/A | Downgrades | 4 years ago |
Mediwound LtdMDWD | 1 | Buy | $84.00 | N/A | Maintains | 6 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $2,520.00 | N/A | Maintains | 6 years ago |
Medicines CoMDCO | 2 | Buy | N/A | N/A | Upgrades | 6 years ago |
Neuroderm LtdNDRM | 2 | Buy | $42.00 | N/A | Upgrades | 7 years ago |
Therapeuticsmd IncTXMD | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.